DRKS00023877已完成未知
Evaluation of SARS-CoV2-specific serum parameters in blood samples of SARS-CoV2-seronegative healthy volunteers, hospitalized SARS-CoV2-patients with acute disease and recovered SARS-CoV2-patients with asymptomatic/mild/severe disease. - COVIAS - SARS-CoV-2-Induced Alterations in Serum Parameters
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 113
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Signed informed consent.
- •2. At least one positive SARS-CoV-2 swab/PCR-test (groups b-e).
- •3. Availability of data (e.g. discharge letters) to assign the patient in one of the groups (asymptomatic/mild/severe) and to document the course of the COVID-19-disease.
- •4. Subject/patient is at least 18 years old and able to give informed consent.
排除标准
- •1. Every disease or status that does not allow the blood drawing according to the assessment of the consenting physician.
研究者
相似试验
已完成
不适用
Evaluation of SARS-CoV2-specific serum parameters in blood samples of hospitalized COVID-19 patients with acute disease and recovered COVID-19 patients with asymptomatic disease (HTXCOV-01K)07.1DRKS00028158Heidelberg ImmunoTherapeutics GmbH16
已完成
不适用
Evaluation of SARS-CoV-2-specific Serumparameters in Blood Samples of SARS-CoV-2-seronegative Volunteers as well as former Patients with Healed, Asymptomatic, Mild or Severe COVID-19-Courses (HTXCOV-01B)07.1GU09.9GDRKS00025863Heidelberg ImmunoTherapeutics GmbH35
招募中
不适用
Evaluation of SARS-CoV-2-specific Serum parameter in Blood of Patients with present post COVID (VANCOV-01)U09.9Post COVID-19 condition, unspecifiedDRKS00032918VANUDIS GmbH60
尚未招募
不适用
SARS CoV 2 antibody status of health care workers in a covid tertiary care hospital in Bangalore, Karnataka.CTRI/2021/03/031933Rajarajeswari medical college and hospital
尚未招募
不适用
Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health WorkersCOVID-19JPRN-UMIN000042599St. Marianna University School of Medicine30